Status:
RECRUITING
Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Obesity
Vasodilation
Eligibility:
All Genders
18-45 years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this project is to examine key mechanisms contributing to sex-differences in hypoxic vasodilation and the impact of obesity, with particular emphasis on the sympathetic nervous system.
Detailed Description
Patients with sleep apnea are at increased risk of developing cardiovascular disease - with women at potentially greater risk than men. Contributing mechanisms are not well understood, but may be rela...
Eligibility Criteria
Inclusion
- BMI \>18 kg/m2
Exclusion
- Pregnancy, breastfeeding
- Diagnosed sleep apnea or AHI \>10 events/hr
- Current smoking/Nicotine use
- Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy
- Nerve/neurologic disease
- Cardiovascular, hepatic, renal, respiratory disease
- Blood pressure ≥140/90 mmHg
- Diabetes, Polycystic ovarian syndrome
- Communication barriers
- Prescription medications, Sensitivity to lidocaine
Key Trial Info
Start Date :
March 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT05219799
Start Date
March 14 2023
End Date
June 30 2026
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri
Columbia, Missouri, United States, 65211